Showing 2,014 articles by Keith Alcorn

Filters Content type: News, About HIV Author: Keith Alcorn

Keith joined NAM’s staff team in 1991 and was our Senior Editor until 2018. He currently contributes news and conference reporting to aidsmap.com and edits infohep.org, our website covering hepatitis treatment news.

Further case report of lactic acidosis linked to tenofovir/ddI

News
29 September 2003

Atazanavir access widened in UK

News
25 September 2003
HIV treatment

Lymph node removal may extend treatment interruption, suggest US research groups

News
22 September 2003
How HIV works

HIV reservoir can be targeted, flushed: pioneers see role in treatment interruption

News
22 September 2003
Treatment simplification strategies

Kaletra monotherapy: unorthodox but effective regimen challenges the rules

News
19 September 2003

South Africa: MCC back pedals on nevirapine for mums to be

News
15 September 2003

Compulsory licensing struggles continue: Cambodia loses rights as Brazil seeks new rights

News
13 September 2003

Long-term evidence for effectiveness of nevirapine in reducing mother-to-child HIV-1 transmission

News
12 September 2003

WTO drug deal will create barriers for HIV treatment, say advocates

News
3 September 2003

Treatment response at six months best guide to long-term prognosis

News
29 August 2003

Treatment interruption shows no benefit in HIV patients with drug resistance

News
28 August 2003
PEP

T-20 for post-exposure prophylaxis?

News
21 August 2003
Drug interactions & pharmacokinetics

Warning on atazanavir and tenofovir combination

News
15 August 2003

South African HIV treatment costs, scope of plan, begin to emerge

News
9 August 2003

South African cabinet endorses ARV roll-out

News
8 August 2003

Treatment Action Campaign welcomes South Africa ARV decision

News
8 August 2003
Health services & systems

Mexico plans free AIDS treatment

News
7 August 2003
HIV treatment for children & young people

Child survival strongly linked to maternal survival in Uganda

News
5 August 2003

South African drug agency questions use of nevirapine for mums to be

News
1 August 2003

WHO plans global ARV purchasing system by end of 2003

News
31 July 2003

WHO promises 3 million on treatment by 2005, but how?

News
31 July 2003

Fos-amprenavir (433908) shows signs of weakness in Kaletra comparison

News
28 July 2003

Abacavir/3TC/tenofovir study stopped due to high failure rate

News
21 July 2003

US HIV guidelines: choose either lopinavir or efavirenz in first-line treatment

News
18 July 2003